These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Benign cellular fibrous histiocytoma with erosion of the phalanx]. Kurzen H; Hartschuh W Hautarzt; 2003 May; 54(5):453-6. PubMed ID: 12719866 [TBL] [Abstract][Full Text] [Related]
24. Cutaneous and subcutaneous fibrohistiocytic tumors of intermediate malignancy: an update. Billings SD; Folpe AL Am J Dermatopathol; 2004 Apr; 26(2):141-55. PubMed ID: 15024197 [TBL] [Abstract][Full Text] [Related]
25. The expression levels and the differential expression of transforming growth factor-beta receptors in dermatofibroma and dermatofibrosarcoma protuberans. Kubo M; Ihn H; Yamane K; Tamaki K Br J Dermatol; 2006 May; 154(5):919-25. PubMed ID: 16634896 [TBL] [Abstract][Full Text] [Related]
26. p53 protein immunoreactivity in fibrohistiocytic tumors of the skin. Lee CS; Chou ST Pathology; 1998 Aug; 30(3):272-5. PubMed ID: 9770192 [TBL] [Abstract][Full Text] [Related]
31. Differential expression of connective tissue growth factor gene in cutaneous fibrohistiocytic and vascular tumors. Igarashi A; Hayashi N; Nashiro K; Takehara K J Cutan Pathol; 1998 Mar; 25(3):143-8. PubMed ID: 9550312 [TBL] [Abstract][Full Text] [Related]
32. Atypical fibroxanthoma and malignant fibrous histiocytoma of the skin. Rizzardi C; Angiero F; Melato M Anticancer Res; 2003; 23(2C):1847-51. PubMed ID: 12820468 [TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans. Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669 [TBL] [Abstract][Full Text] [Related]
34. nm23 protein expression and p53 immunoreactivity in cutaneous fibrohistiocytic tumors. Lee CS; Clarke RA; Tran KT; Kearsley JH; Chou ST Pathology; 1999 May; 31(2):123-6. PubMed ID: 10399167 [TBL] [Abstract][Full Text] [Related]
35. Sclerosing Dermatofibrosarcoma Protuberans Shows Significant Overlap With Sclerotic Fibroma in Both Routine and Immunohistochemical Analysis: A Potential Diagnostic Pitfall. Abdaljaleel MY; North JP Am J Dermatopathol; 2017 Feb; 39(2):83-88. PubMed ID: 28134725 [TBL] [Abstract][Full Text] [Related]